Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade
Luo, Yan, Shreeder, Barath, Jenkins, James W, Shi, Huashan, Lamichhane, Purushottam, Zhou, Kexun, Bahr, Deborah A, Kurian, Sophia, Jones, Katherine A, Daum, Joshua I, Dutta, Navnita, Necela, Brian M, Cannon, Martin J, Block, Matthew S, Knutson, Keith L
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers
Ailawadhi, Sikander, Ailawadhi, Meghna, Dutta, Navnita, Parrondo, Ricardo D., Roy, Vivek, Sher, Taimur, Baksh, Mizba, Rasheed, Ahsan, Das, Saurav, Fernandez, Andre J., Paulus, Aneel, Chanan‐Khan, Asher A.
Published in Cancer medicine (Malden, MA) (01.09.2023)
Published in Cancer medicine (Malden, MA) (01.09.2023)
Get full text
Journal Article
Analysis of biomarkers in melanoma patients receiving ICI treatments: pre- vs post in responders and progressors
Daftarian, Pirouz M, Nadine, Nadine, Hushur, Orkash, Dronca, Roxana, Dutta, Navnita, Knutson, Keith L
Published in The Journal of immunology (1950) (01.05.2022)
Published in The Journal of immunology (1950) (01.05.2022)
Get full text
Journal Article
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Deng, Jing, Paulus, Aneel, Fang, Douglas D, Manna, Alak, Wang, Guangfeng, Wang, Hengbang, Zhu, Saijie, Chen, Jianyong, Min, Ping, Yin, Yan, Dutta, Navnita, Halder, Nabanita, Ciccio, Gina, Copland, John A, Miller, James, Han, Bing, Bai, Longchuan, Liu, Liu, Wang, Mi, McEachern, Donna, Przybranowski, Sally, Yang, Chao-Yie, Stuckey, Jeanne A, Wu, Depei, Li, Caixia, Ryan, Jeremy, Letai, Anthony, Ailawadhi, Sikander, Yang, Dajun, Wang, Shaomeng, Chanan-Khan, Asher, Zhai, Yifan
Published in Clinical cancer research (15.12.2022)
Published in Clinical cancer research (15.12.2022)
Get full text
Journal Article
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia
Parrondo, Ricardo D., Dutta, Navnita, LaPlant, Betsy R., Elliott, Jamie, Fernandez, Andre, Zimmerman, Ashley, Cicco, Gina, Han, Bing, Heslop, Keisha, Chapin, Dustin, Sher, Taimur, Roy, Vivek, Rasheed, Ahsan, Das, Saurav, Chanan‐Khan, Asher A., Paulus, Aneel, Ailawadhi, Sikander
Published in British journal of haematology (01.05.2024)
Published in British journal of haematology (01.05.2024)
Get full text
Journal Article
Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis
Kumar, Vivek, Ailawadhi, Meghna, Dutta, Navnita, Abdulazeez, Mays, Aggarwal, Chander Shekher, Quintero, Gerson, Baksh, Mizba, Roy, Vivek, Sher, Taimur, Alegria, Victoria, Paulus, Aneel, Chanan-Khan, Asher, Ailawadhi, Sikander
Published in Clinical lymphoma, myeloma and leukemia (01.05.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.05.2021)
Get full text
Journal Article
Abstract 1464: Inhibition of p38 MAPK in dendritic cells enhances their antigen presentation and induces Th17 T cell differentiation
Luo, Yan, Barath, Shreeder, Bahr, Deborah A., Dutta, Navnita, Raja, Geraldine, Cannon, Martin J., Knutson, Keith L.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
Ailawadhi, Sikander, Parrondo, Ricardo D, Dutta, Navnita, Han, Bing, Ciccio, Gina, Cherukuri, Yesesri, Alegria, Victoria R, LaPlant, Betsy R, Roy, Vivek, Sher, Taimur, Edwards, Brett, Lanier, Stephanie, Manna, Alak, Heslop, Keisha, Caulfield, Thomas, Maldosevic, Emir, Storz, Peter, Manochakian, Rami, Asmann, Yan, Chanan-Khan, Asher A, Paulus, Aneel
Published in Cancers (12.01.2023)
Published in Cancers (12.01.2023)
Get full text
Journal Article
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
Manna, Alak, Kellett, Timothy, Aulakh, Sonikpreet, Lewis-Tuffin, Laura J., Dutta, Navnita, Knutson, Keith, Chini, Eduardo, Pinilla-Ibarz, Javier, Lamanna, Nicole, Manochakian, Rami, Malavasi, Fabio, Sher, Taimur, Chanan-Khan, Asher A., Ailawadhi, Sikander, Paulus, Aneel
Published in Blood advances (26.05.2020)
Published in Blood advances (26.05.2020)
Get full text
Journal Article